National Institutes of Health supports novel drug discovery research

Approximately $1.7 million in new funding from the National Institutes of Health will enable a multidisciplinary team of University of Illinois at Chicago researchers to build a reference library of bacteria to help scientists quickly identify bacterial strains and analyze their disease-fighting potential. 12th International Conference on Pharmaceutical Chemistry during May 20-21, 2019 at Berlin, Germany.  The conference emphasizes the theme “Exploring the Challenges in…

Robotic System could Reduce the Cost of Drug Discovery

Developing a new drug is expensive and time-consuming. One major challenge is the sheer number of experiments needed to prove a drug is safe. Literally thousands of experiments with each potential treatment represents a huge investment in time and money. Robotic systems might hold the key to reducing development costs and also speeding up the…

Fingerprint #drug screen test works on the living and deceased

A revolutionary #drug test developed from research carried out at the University of East Anglia can detect four classes of drugs in traces of sweat found in a #fingerprint. And the technology works on both the living and deceased. New research published in the Journal of Analytical Toxicology shows how the Intelligent Fingerprinting #Drug Screening System enables…

Opioid-Induced Constipation: A New Drug to Treat the Side Effects of Opioids

During the 2016 Super Bowl, an advertisement featured a man suffering from opioid-induced constipation. Superficially, the commercial appeared to raise awareness of a distressing condition and suggest a solution to the problem. On a deeper level, it kicked off a discussion on how opioid-induced constipation might be better addressed by first reducing the use of…

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. 12th International Conference on Pharmaceutical Chemistry from May 20-21, 2019 at Berlin, Germany. For more details kindly visit www.meetingsint.com/conferences/pharmachemistry The team hope the compound -developed after 10 years of painstaking research will be trialed on humans within three…

Type 2 diabetes: Poor sleep slows wound healing

  A new study, published recently in the journal SLEEP, studied the impact of sleep fragmentation on wound healing. The scientists compared obese mice with features of type 2 diabetes with normal-weight mice without type 2 diabetes. First study author Mark McLain, of the University of Tennessee at Knoxville, collaborated with Prof. Ralph Lydic and…

US approves MSD HIV drugs Delstrigo and Pifeltro

Delstrigo is a once-daily fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate, while Pifeltro is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral medicines. In DRIVE-AHEAD trial, 728 participants with no antiretroviral treatment history were randomized and received at least one dose of either Delstrigo or…

New Therapy Could Reverse Type 1 Diabetes In Humans And Dogs

Researchers at Purdue University and Indiana University School of Medicine (IU) are working with man’s best friend to cure one of his most insidious diseases. The scientists say a new therapy shows promise for long-term reversal of Type 1 diabetes in both humans and dogs. Purdue reported this week that scientists achieved normal glucose levels…

Zydus Cadila gets USFDA nod to market 2 products

Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market Gemfibrozil tablets and Aripiprazole orally disintegrating tablets in the US. The company has received USFDA‘s final clearance to market Gemfibrozil tablets in strength of 600 mg and the other product in strengths of 10 mg, 15 mg, 20 mg, and 30…